Annual CFI
$22.34 M
+$20.36 M+1028.33%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual cash flow from investing activities is $22.34 million, with the most recent change of +$20.36 million (+1028.33%) on December 31, 2023.
- During the last 3 years, IPHA annual CFI has risen by +$37.60 million (+246.28%).
- IPHA annual CFI is now -66.65% below its all-time high of $66.97 million, reached on December 31, 2016.
Performance
IPHA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IPHA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1028.3% | - | - |
| 3 y3 years | +246.3% | - | - |
| 5 y5 years | -22.1% | - | - |
IPHA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2158.6% | ||||
| 5 y | 5-year | at high | +132.1% | ||||
| alltime | all time | -66.7% | +117.4% |
Innate Pharma SA Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $22.34 M(+1028.3%) | - | - |
| Dec 2022 | $1.98 M(-282.4%) | - | - |
| Dec 2021 | -$1.08 M(-92.9%) | - | - |
| Dec 2020 | -$15.27 M(-78.0%) | - | - |
| Dec 2019 | -$69.54 M(-342.6%) | - | - |
| Dec 2018 | $28.67 M(-185.9%) | - | - |
| Dec 2017 | -$33.36 M(-149.8%) | - | - |
| Dec 2016 | $66.97 M(-152.0%) | - | - |
| Dec 2015 | -$128.69 M(+2431.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$5.08 M(+299.6%) | - | - |
| Dec 2013 | -$1.27 M(-63.1%) | - | - |
| Dec 2012 | -$3.45 M(-201.2%) | - | - |
| Dec 2011 | $3.41 M(-989.9%) | - | - |
| Dec 2010 | -$383.10 K(-101.5%) | - | - |
| Dec 2009 | $26.41 M(-20.1%) | - | - |
| Dec 2008 | $33.06 M(+384.7%) | - | - |
| Dec 2007 | $6.82 M(-113.9%) | - | - |
| Dec 2006 | -$49.00 M(+2653.4%) | - | - |
| Dec 2005 | -$1.78 M | - | - |
FAQ
- What is Innate Pharma SA annual cash flow from investing activities?
- What is the all time high annual CFI for Innate Pharma SA?
- What is Innate Pharma SA annual CFI year-on-year change?
What is Innate Pharma SA annual cash flow from investing activities?
The current annual CFI of IPHA is $22.34 M
What is the all time high annual CFI for Innate Pharma SA?
Innate Pharma SA all-time high annual cash flow from investing activities is $66.97 M
What is Innate Pharma SA annual CFI year-on-year change?
Over the past year, IPHA annual cash flow from investing activities has changed by +$20.36 M (+1028.33%)